GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Granules India Ltd (NSE:GRANULES) » Definitions » EBITDA Margin %

Granules India (NSE:GRANULES) EBITDA Margin % : 21.60% (As of Sep. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Granules India EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Granules India's EBITDA for the three months ended in Sep. 2024 was ₹2,066 Mil. Granules India's Revenue for the three months ended in Sep. 2024 was ₹9,565 Mil. Therefore, Granules India's EBITDA margin for the quarter that ended in Sep. 2024 was 21.60%.


Granules India EBITDA Margin % Historical Data

The historical data trend for Granules India's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Granules India EBITDA Margin % Chart

Granules India Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.96 27.39 19.54 20.17 18.40

Granules India Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.06 21.73 19.28 22.15 21.60

Competitive Comparison of Granules India's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Granules India's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Granules India's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Granules India's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Granules India's EBITDA Margin % falls into.



Granules India EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Granules India's EBITDA Margin % for the fiscal year that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Mar. 2024 )/Revenue (A: Mar. 2024 )
=8263.2/44901.6
=18.40 %

Granules India's EBITDA Margin % for the quarter that ended in Sep. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=2065.74/9565.21
=21.60 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Granules India  (NSE:GRANULES) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Granules India EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Granules India's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Granules India Business Description

Traded in Other Exchanges
Address
3rd Block, 2nd Floor, My Home Hub, Madhapur, Hyderabad, TG, IND, 500081
Granules India Ltd is an India-based pharmaceutical company. The company manufactures active pharmaceutical ingredients, pharmaceutical formulation intermediates, and finished dosages. It has one segment Pharmaceutical products including ingredients and intermediaries. Its primary geographic markets are North America, Latin America, Europe, India, and the Rest of the World. The company generates a majority of its revenue from its business outside India.

Granules India Headlines

No Headlines